Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Sales | 108 | 14 | 225 | 1,673 | 8 |
| Operating Expenses | 487 | 783 | 1,716 | 11,962 | 433 |
| Operating Income | -380 | -769 | -1,491 | -10,288 | -424 |
| Interest Expense | 66 | 129 | 159 | 468 | 25 |
| Other Income | -792 | -262 | 9,825 | -228 | -445 |
| Pre-tax Income | -1,238 | -1,160 | 8,176 | -10,984 | -894 |
| Net Income Continuous | -1,238 | -1,160 | 8,176 | -10,984 | -894 |
| Minority Interests | 0 | 378 | 378 | N/A | N/A |
| Net Income | $-1,238 | $-782 | $8,554 | $-6,776 | $-894 |
| EPS Basic Total Ops | 0.00 | 0.00 | 0.30 | -0.28 | -0.03 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | 0.30 | -0.28 | -0.03 |
| EPS Diluted Total Ops | 0.00 | 0.00 | 0.30 | -0.28 | -0.03 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | 0.30 | -0.28 | -0.03 |
| EBITDA(a) | $-1,147 | $-1,007 | $8,615 | $-9,616 | $-785 |